These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8605839)
1. [Decreasing the antihypertensive dosage during longterm treatment and complete regression of left ventricular hypertrophy]. Franz IW; Behr U; Ketelhut R; Tönnesmann U Dtsch Med Wochenschr; 1996 Apr; 121(15):472-7; discussion 478. PubMed ID: 8605839 [TBL] [Abstract][Full Text] [Related]
2. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design. Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R; J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371 [TBL] [Abstract][Full Text] [Related]
3. Effects of fixed combination of lisinopril plus hydrochlorothiazide on regression of left ventricular hypertrophy in patients with essential hypertension: an opened, multi-centre, prospective clinical trial. Gerc V; Begović B; Vehabović M; Georgievich Voronkov L; Vataman E; Musić L; Buksa M; Kusljugić Z; Baraković F; Iosifovna Tchelujko V; Ivanovich Dyaduk A; Alekseevna Andrievskaja S; Eduardovich Bagrij A; Nikolaevich Polivoda S; Lazarević A; Knezević B; Hima F Bosn J Basic Med Sci; 2008 Aug; 8(3):214-9. PubMed ID: 18816251 [TBL] [Abstract][Full Text] [Related]
4. [The effect of hypotensive drugs on left ventricular mass and diastolic function]. Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699 [TBL] [Abstract][Full Text] [Related]
5. Effect of perindopril and metoprolol on left ventricular hypertrophy and performance in essential hypertension. Hui Y; Dai Z; Chen X; Wang W Chin Med J (Engl); 1995 Sep; 108(9):678-81. PubMed ID: 8575234 [TBL] [Abstract][Full Text] [Related]
6. Time course of reduction in left ventricular mass during long-term antihypertensive therapy. Franz IW; Ketelhut R; Behr U; Tönnesmann U J Hum Hypertens; 1994 Mar; 8(3):191-8. PubMed ID: 8006919 [TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910 [TBL] [Abstract][Full Text] [Related]
8. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial. Cağlar N; Dincer I Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296 [TBL] [Abstract][Full Text] [Related]
9. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise. Ketelhut S; Franz IW; Ketelhut RG High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642 [TBL] [Abstract][Full Text] [Related]
10. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study. Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study. Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A; J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969 [TBL] [Abstract][Full Text] [Related]
12. Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors. Franz IW; Tönnesmann U; Müller JF Am J Hypertens; 1998 Jun; 11(6 Pt 1):631-9. PubMed ID: 9657621 [TBL] [Abstract][Full Text] [Related]
13. Arterial hypertension increases left ventricular mass: role of tight blood pressure control. Ferrara LA; Vaccaro O; Cardoni O; Mancini M; Zanchetti A J Hum Hypertens; 2004 Sep; 18(9):637-42. PubMed ID: 15014537 [TBL] [Abstract][Full Text] [Related]
14. Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapy. Mizuno R; Fujimoto S; Saito Y; Yamazaki M Heart; 2016 Jun; 102(11):849-54. PubMed ID: 26839069 [TBL] [Abstract][Full Text] [Related]
15. Physical performance is preserved after regression of left ventricular hypertrophy. Lacourcière Y; Poirier L; Cléroux J J Cardiovasc Pharmacol; 1997 Sep; 30(3):383-91. PubMed ID: 9300324 [TBL] [Abstract][Full Text] [Related]
16. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients. Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714 [TBL] [Abstract][Full Text] [Related]
17. Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH. Novo S; Abrignani MG; Novo G; Nardi E; Dominguez LJ; Strano A; Barbagallo M Am J Hypertens; 2001 Jul; 14(7 Pt 1):637-43. PubMed ID: 11465647 [TBL] [Abstract][Full Text] [Related]
18. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin. Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920 [TBL] [Abstract][Full Text] [Related]
19. Effects of diltiazem, metoprolol, enalapril and hydrochlorothiazide on frequency of ventricular premature complexes. Papademetriou V; Narayan P; Kokkinos P Am J Cardiol; 1994 Feb; 73(4):242-6. PubMed ID: 7507638 [TBL] [Abstract][Full Text] [Related]
20. Long-term effect of antihypertensive therapy on left ventricular hypertrophy. Franz IW; Tönnesmann U; Behr U; Ketelhut R J Hypertens Suppl; 1987 Dec; 5(5):S415-8. PubMed ID: 2965229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]